Matches in SemOpenAlex for { <https://semopenalex.org/work/W2290413013> ?p ?o ?g. }
- W2290413013 abstract "Hematological malignancies are a group of neoplasms that originate from the bone marrow or lymphatic tissues representing close to 10% of the overall cancer burden in the world. Clinical course, prognosis and survival varies greatly from very aggressive disease requiring intensive systemic chemotherapy-based treatment to indolent forms without need of therapy at diagnosis. Patients are typically diagnosed at old age and may have other comorbid diseases that have to be taken into account for optimal treatment and care. Comorbid diseases may constitute risk factors for the development of subtypes of hematological malignancies, and/or determinants of complications and death. The aim of this thesis was to evaluate the association and impact of comorbid diseases on mortality in leukemia, myeloma and lymphoma, risk of suicidal behavior and death following diagnoses of hematological malignancies, especially considering mental comorbidity, and finally evaluating appendectomy as a potential risk factor for hematological malignancy of lymphoid origin. The study cohorts of the four papers in this thesis were created by linkage between Swedish national health care registers (studies I-III) and the national Swedish quality register for lymphoma (study IV). In study I, we evaluated risk of attempted and completed suicide in a cohort of 46,309 patients diagnosed with lymphoma, myeloma or leukemia in Sweden 1992-2009 compared with a set of cancer-free individuals using Poisson regression. The relative risk of completed suicide was 3.5-fold increased among patients with myeloma and 1.9-fold increased among patients with lymphoma but not significantly increased among patients with leukemia. Risk of attempted suicide was also increased among patients with myeloma and lymphoma. History of mental disorders conferred highly increased risks. Next (study II), we evaluated the association and impact of comorbidity in general and specific comorbid diseases (defined according to the Charlson index) on all-cause and cancerspecific mortality in patients with acute myeloid leukemia (AML), chronic myeloid leukemia (CML) or myeloma, accounting for competing risks in analyses of cancer-specific death. Comorbidity was associated with increased all-cause as well as cancer-specific mortality. Disorders associated with higher cancer-specific mortality were renal disease (in AML, CML, myeloma), cerebrovascular conditions, dementia, psychiatric disease (AML, myeloma), liver and rheumatic disease (AML), cardiovascular and pulmonary disease (myeloma). In study III, we evaluated the association between comorbid disease history and lymphoma characteristics, treatment selection and lymphoma-specific mortality among patients with diffuse large B-cell lymphoma (DLBCL), an aggressive lymphoma subtype. Comorbid patients had a significantly higher relative probability of presenting with low performance status compared with patients without comorbidity, and a lower relative probability of receiving curative treatment, leading to increased risks of all-cause as well as lymphomaspecific death. Among patients selected for curative treatment, comorbid disease was associated with all-cause but not lymphoma-specific death. Finally, in study IV, in light of mixed results in previous studies, we examined risk of lymphoid neoplasms in a cohort of 337,437 appendectomized patients <60 years of age in Sweden 1975-2009. We did not observe any clear associations between appendectomy and risk of non-Hodgkin lymphoma overall or major subtypes, myeloma or acute lymphoblastic leukemia. An increased risk of Hodgkin lymphoma was noted among patients diagnosed with appendicitis and for the nodular sclerosis subtype of HL, which could reflect a true association, or shared susceptibility to infection/inflammation among individuals prone to develop HL. LIST OF SCIENTIFIC PAPERS This thesis is based on following manuscripts which will be referred to in the text by their roman numerals (I-IV): I. Mohammadi M, Moradi T, Bottai M, Reutfors J, Cao Y, Smedby KE. Risk and predictors of attempted and completed suicide in patients with hematological malignancies. Psychooncology. 2014 Nov;23(11):1276-82 II. Mohammadi M, Cao Y, Glimelius I, Bottai M, Eloranta S, Smedby KE. The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma a Swedish population-based study. BMC Cancer. 2015 Nov 5;15:850 III. Mohammadi M, Eloranta S, Glimelius I, Cao Y, Jerkeman Mats, Bottai M, Smedby KE. Comorbid disease history and associations with disease characteristics, treatment intent and mortality in diffuse large B-cell lymphoma – a Swedish lymphoma register study. Manuscript IV. Mohammadi M, Song H, Cao Y, Glimelius I, Ekbom A, Ye W, Smedby KE. Risk of lymphoid neoplasms in a Swedish population-based cohort of 337,437 patients undergoing appendectomy. Scand J Gastroenterol. 2015 December;51(5):583-9 (E-pub) CONTENTS" @default.
- W2290413013 created "2016-06-24" @default.
- W2290413013 creator A5050882292 @default.
- W2290413013 date "2016-03-01" @default.
- W2290413013 modified "2023-09-23" @default.
- W2290413013 title "COMORBIDITY IN RISK AND OUTCOME OF HEMATOLOGICAL MALIGNANCIES" @default.
- W2290413013 cites W1157339290 @default.
- W2290413013 cites W1491714528 @default.
- W2290413013 cites W1536569285 @default.
- W2290413013 cites W1549731537 @default.
- W2290413013 cites W1561716061 @default.
- W2290413013 cites W1621819736 @default.
- W2290413013 cites W166655658 @default.
- W2290413013 cites W1670252681 @default.
- W2290413013 cites W1789507134 @default.
- W2290413013 cites W1806999293 @default.
- W2290413013 cites W180867326 @default.
- W2290413013 cites W1836390862 @default.
- W2290413013 cites W1911120442 @default.
- W2290413013 cites W1958778438 @default.
- W2290413013 cites W1965157522 @default.
- W2290413013 cites W1966641706 @default.
- W2290413013 cites W1967037070 @default.
- W2290413013 cites W1968185636 @default.
- W2290413013 cites W1968313018 @default.
- W2290413013 cites W1969080284 @default.
- W2290413013 cites W1971050658 @default.
- W2290413013 cites W1974938631 @default.
- W2290413013 cites W1975237753 @default.
- W2290413013 cites W1978698920 @default.
- W2290413013 cites W1980863661 @default.
- W2290413013 cites W1981480737 @default.
- W2290413013 cites W1982588049 @default.
- W2290413013 cites W1983905269 @default.
- W2290413013 cites W1985645817 @default.
- W2290413013 cites W1986769067 @default.
- W2290413013 cites W1986892201 @default.
- W2290413013 cites W1987455200 @default.
- W2290413013 cites W1988463165 @default.
- W2290413013 cites W1990319048 @default.
- W2290413013 cites W1990756289 @default.
- W2290413013 cites W1990764817 @default.
- W2290413013 cites W1992358532 @default.
- W2290413013 cites W1995836691 @default.
- W2290413013 cites W1997468904 @default.
- W2290413013 cites W1998204086 @default.
- W2290413013 cites W1998585251 @default.
- W2290413013 cites W1998612006 @default.
- W2290413013 cites W1998679731 @default.
- W2290413013 cites W2000445173 @default.
- W2290413013 cites W2000652654 @default.
- W2290413013 cites W2002130312 @default.
- W2290413013 cites W2002628171 @default.
- W2290413013 cites W2002764656 @default.
- W2290413013 cites W2005556924 @default.
- W2290413013 cites W2005624571 @default.
- W2290413013 cites W2006053083 @default.
- W2290413013 cites W2007475152 @default.
- W2290413013 cites W2011280987 @default.
- W2290413013 cites W2011444159 @default.
- W2290413013 cites W2012130476 @default.
- W2290413013 cites W2013151816 @default.
- W2290413013 cites W2014324440 @default.
- W2290413013 cites W2016740804 @default.
- W2290413013 cites W2016911502 @default.
- W2290413013 cites W2016969330 @default.
- W2290413013 cites W2018195863 @default.
- W2290413013 cites W2023948557 @default.
- W2290413013 cites W2024308747 @default.
- W2290413013 cites W2027957809 @default.
- W2290413013 cites W2028156878 @default.
- W2290413013 cites W2028710252 @default.
- W2290413013 cites W2029268744 @default.
- W2290413013 cites W2033511562 @default.
- W2290413013 cites W2034030408 @default.
- W2290413013 cites W2034677707 @default.
- W2290413013 cites W2038062093 @default.
- W2290413013 cites W2038437261 @default.
- W2290413013 cites W2043705060 @default.
- W2290413013 cites W2046685309 @default.
- W2290413013 cites W2050654184 @default.
- W2290413013 cites W2052059036 @default.
- W2290413013 cites W2053563324 @default.
- W2290413013 cites W2055190439 @default.
- W2290413013 cites W2056075785 @default.
- W2290413013 cites W2057780602 @default.
- W2290413013 cites W2058033953 @default.
- W2290413013 cites W2058188142 @default.
- W2290413013 cites W2058362335 @default.
- W2290413013 cites W2060020125 @default.
- W2290413013 cites W2061326496 @default.
- W2290413013 cites W2063691874 @default.
- W2290413013 cites W2069754702 @default.
- W2290413013 cites W2070478828 @default.
- W2290413013 cites W2071244728 @default.
- W2290413013 cites W2072430038 @default.
- W2290413013 cites W2072586345 @default.
- W2290413013 cites W2074015360 @default.
- W2290413013 cites W2074791309 @default.
- W2290413013 cites W2075459662 @default.